Israel’s TopGum acquires Abbey Nutritionals Canadian functional supplements firm
TopGum which operates its own advanced gummy supplement business, has expanded with a key Canadian purchase. Pic: TopGum
Israeli-headquartered TopGum, a specialist in gummy supplements has struck a milestone deal worth more than $20 million to acquire Canadian manufacturer Abbey Nutritionals, producing functional lozenges, reports Neill Barston.
As the business asserted, taking on the Prince Edward Island firm represents a strong strategic move in terms of its overall manufacturing and technology capabilities for its international product development operations.
According to TopGum, the purchase will aid its growth of the “Enjoyables” supplement segment through organic expansion and strategic acquisitions. The transaction is expected to propel the company’s annual revenue run-rate beyond USD100 million, further solidifying its position as the partner of choice to household brands and customers worldwide.
The deal will also reportedly involve additional payments beyond the core price for the deal, and is expected to clear during the first quarter of 2025, and is subject to regular regulatory deal clearance terms.
Founded in 2004, Island Abbey has established itself as a key player in gummy and lozenge delivery formats for dietary supplements. Under the leadership of CEO Dean Williams, it recorded remarkable growth in recent years, driven by its R&D and operational excellence.
Island Abbey operates an advanced facility spanning 65,000 ft², in which tens of millions of dollars were invested in the last couple of years. Equipped with advanced manufacturing technologies, including starchless depositing, centre-fill capabilities, and automated bottling and packaging lines, the facility adheres to stringent quality standards such as FDA, NSF, GMP, SQF, and Health Canada certifications.
The acquisition bolsters TopGum’s strategic focus to deepen its foothold in the US market. By integrating Island Abbey’s advanced capabilities, TopGum will establish an integrated supply chain with production, bottling and warehousing capabilities across two continents. The combined expertise and expanded capacity will enable TopGum to meet increasing global demand for high-quality, differentiated gummy supplements — delivering exceptional taste and reliability to its partners.
“Island Abbey brings a unique combination of strategic customers, advanced technologies, and a professional, experienced team,” says Eyal Shohat, CEO of TopGum. “Together with TopGum’s longstanding expertise, this partnership opens new horizons for innovation and growth. Our combined teams will continue to develop advanced solutions that deliver a wellness experience that is fun, easy, and tasty. We are reinforcing our commitment to our business partners and customers worldwide as we embark on this exciting new chapter in TopGum’s global growth story.”
As part of the transaction, Island Abbey will maintain its operational independence while leveraging TopGum’s global reach and resources. Island Abbey’s 95 employees will remain in place, led by CEO Dean Williams, a veteran of the consumer goods and nutritional supplement industries. Williams will be joining TopGum’s Executive Leadership team.
“I’m honoured to be part of this pivotal moment for Island Abbey,” notes Dean Williams, CEO of Island Abbey. “This acquisition reflects our success in advancing supplement solutions across Canada and the US. The combination of these two entities is poised to redefine the gummy supplement market.”
A Vision for Growth and Innovation
“We are deeply impressed by Island Abbey’s journey, particularly under Dean’s leadership”, expresses Hagai Stadler, Chairman of TopGum. “We are proud to welcome Island Abbey to the TopGum family. Together, we will build on Island Abbey’s legacy and create a vital component of TopGum’s mission to become a dominant global player in the supplement industry.”
